Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from Calumet Specialty Products ( (CLMT) ).
Stephen Mawer, Chair of the Board of Directors of Calumet, Inc., adopted a trading plan on November 15, 2024, to comply with Rule 10b5-1(c) under the Securities Exchange Act. The plan, which began on March 6, 2025, and was set to end on December 31, 2025, allowed for the sale of up to 40,205 shares of common stock. However, on May 13, 2025, Mr. Mawer terminated the plan after 10,965 shares had been sold.
The most recent analyst rating on (CLMT) stock is a Buy with a $25.00 price target. To see the full list of analyst forecasts on Calumet Specialty Products stock, see the CLMT Stock Forecast page.
Spark’s Take on CLMT Stock
According to Spark, TipRanks’ AI Analyst, CLMT is a Neutral.
Calumet’s overall stock score reflects significant financial challenges, including declining revenue and profitability metrics, as well as high leverage and negative equity. While the stock shows strong technical momentum, valuation concerns persist due to a negative P/E ratio and lack of a dividend yield. The earnings call highlighted positive steps in debt reduction and project management, yet market and regulatory hurdles continue to pose risks.
To see Spark’s full report on CLMT stock, click here.
More about Calumet Specialty Products
Average Trading Volume: 1,289,516
Technical Sentiment Signal: Sell
Current Market Cap: $1.21B
For detailed information about CLMT stock, go to TipRanks’ Stock Analysis page.